For: | Zhang MM, Wu XT, Zhou Y, Qian K, Zheng YM. Short-term application of low-dose growth hormone in surgical patients: Effects on nitrogen balance and blood glucose. World J Gastroenterol 2007; 13(3): 452-456 [PMID: 17230618 DOI: 10.3748/wjg.v13.i3.452] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i3/452.htm |
Number | Citing Articles |
1 |
Ceressa T Ward, David W Boorman, Ava Afshar, Amit Prabhakar, Babar Fiza, Laura R Pyronneau, Amber Kimathi, Carmen Paul, Berthold Moser, Vanessa Moll. A Screening Tool to Detect Chronic Critically Ill Cardiac Surgery Patients at Risk for Low Levels of Testosterone and Somatomedin C: A Prospective Observational Pilot Study. Cureus 2021; doi: 10.7759/cureus.15298
|
2 |
A. P. Boesen, K. Dideriksen, C. Couppé, S. P. Magnusson, P. Schjerling, M. Boesen, P. Aagaard, M. Kjaer, H. Langberg. Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation. Journal of Applied Physiology 2014; 116(2): 192 doi: 10.1152/japplphysiol.01077.2013
|
3 |
Lindsay-Rae B. Weitzel, Paul A. Sandoval, W Jonathan Mayles, Paul E. Wischmeyer. Performance-enhancing sports supplements: Role in critical care. Critical Care Medicine 2009; 37: S400 doi: 10.1097/CCM.0b013e3181b6f2e6
|
4 |
Suzie Ferrie, Margaret Allman‐Farinelli. Commonly Used “Nutrition” Indicators Do Not Predict Outcome in the Critically Ill. Nutrition in Clinical Practice 2013; 28(4): 463 doi: 10.1177/0884533613486297
|
5 |
Beth E Taylor, Timothy G Buchman. Is there a role for growth hormone therapy in refractory critical illness?. Current Opinion in Critical Care 2008; 14(4): 438 doi: 10.1097/MCC.0b013e328306a965
|
6 |
A. P. Boesen, K. Dideriksen, C. Couppé, S. P. Magnusson, P. Schjerling, M. Boesen, M. Kjaer, H. Langberg. Tendon and skeletal muscle matrix gene expression and functional responses to immobilisation and rehabilitation in young males: effect of growth hormone administration. The Journal of Physiology 2013; 591(23): 6039 doi: 10.1113/jphysiol.2013.261263
|
7 |
Michael R. Graham, Peter Evans, Non-Eleri Thomas, Bruce Davies, Julien S. Baker. Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology. American Journal Cardiovascular Drugs 2009; 9(6): 371 doi: 10.2165/11312100-000000000-00000
|